OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

ATI INC. DL-,01/  US01741R1023  /

Lang & Schwarz
5/17/2024  10:58:10 PM Chg. -0.76 Volume Bid10:58:10 PM Ask10:58:10 PM Market Capitalization Dividend Y. P/E Ratio
54.46EUR -1.38% -
Turnover: -		 54.46Bid Size: - 56.44Ask Size: - 6.9 bill.EUR - -
GlobeNewswire 5/13 Astrotech Reports Third Quarter of Fiscal Year 2024 Financial Results
GlobeNewswire 5/9 TTM Technologies, Inc. Appoints Wajid Ali to Board of Directors
GlobeNewswire 5/7 Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
GlobeNewswire 3/27 William & Mary Campus Mass Notification Drill Using ATI Systems’ Mass Notification Solution
GlobeNewswire 3/12 Researchers Publish Manuscript on the Prevention and Emergency Response to Tularemia Outbreaks
GlobeNewswire 2/13 Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024
GlobeNewswire 2/6 Seoul Robotics to Pursue Initial Public Offering with Samsung Securities as it Expands OEM Partnersh...
GlobeNewswire 1/25 Confluent Announces Significant Investment in ATI Nitinol Melt Expansion
GlobeNewswire 1/17 IBN Coverage Initiated for Astrotech Corp.
GlobeNewswire 1/16 Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review
GlobeNewswire 12/27/2023 Eco Bright Future, Inc. Announces Signing of "Letter-of-Intent" With United Heritage, Sociedad Anoni...
GlobeNewswire 12/12/2023 Astrotech Announces Exciting New Technology Application and Introduces New Subsidiary
GlobeNewswire 12/5/2023 American Trust Insurance Joins World Insurance Associates
GlobeNewswire 11/27/2023 ATI Systems Honored with 2023 ‘ASTORS’ Homeland Security Award
GlobeNewswire 11/13/2023 Aclaris Therapeutics Announces Top-line Results from 12-Week Phase 2b Trial of Oral Zunsemetinib (AT...
GlobeNewswire 11/6/2023 Aclaris Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
GlobeNewswire 10/27/2023 Strategic Advisory Board Elevates sureti’s Property Claims Resolution Capabilities
GlobeNewswire 10/25/2023 Excision BioTherapeutics Presents Positive Interim Clinical Data from Ongoing Phase 1/2 Trial of EBT...
GlobeNewswire 10/23/2023 ATI PHYSICAL THERAPY INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti...
GlobeNewswire 10/19/2023 Excision BioTherapeutics Announces Presentation of Interim Clinical Data for EBT-101 in Latent HIV a...
GlobeNewswire 10/3/2023 Aclaris Therapeutics Completes Enrollment in Phase 2b Study of ATI-1777 for Mild to Severe Atopic De...
GlobeNewswire 9/30/2023 ATI PHYSICAL THERAPY INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti...
GlobeNewswire 9/19/2023 ATI PHYSICAL THERAPY INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti...
GlobeNewswire 9/18/2023 Aclaris Therapeutics Announces Positive Results from Phase 1 Multiple Ascending Dose Trial of ATI-21...
GlobeNewswire 8/30/2023 Churchill Franklin Automotive Launches Airbag Alert News Service